410914005: Product containing precisely naphazoline hydrochloride 250 microgram/1 milliliter and pheniramine maleate 3 milligram/1 milliliter conventional release eye solution (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Naphazoline (substance)\Naphazoline-containing product in ocular dose form\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Naphazoline (substance)\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Naphazoline (substance)\Product containing naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Histamine receptor antagonist-containing product\Product containing histamine H1 receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Histamine receptor antagonist-containing product\Product containing histamine H1 receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Histamine receptor antagonist-containing product\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Medicinal product categorized by disposition (product)\Histamine receptor antagonist-containing product\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Medicinal product categorized by structure (product)\Nitrogen and/or nitrogen compound-containing product\...

\Product containing propylamine (product)\Product containing propylamine derivative and histamine receptor antagonist (product)\Product containing pheniramine (medicinal product)\Product containing naphazoline and pheniramine (medicinal product)\...

\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Naphazoline and pheniramine only product\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Azole-containing product\Product containing imidazole (product)\Naphazoline (substance)\...

\Naphazoline-containing product in ocular dose form\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Product containing naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Product manufactured as ocular dose form (product)\Naphazoline-containing product in ocular dose form\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Autonomic drug (substance)\Product containing sympathomimetic (product)\Adrenergic receptor agonist-containing product\Product containing alpha adrenergic receptor agonist (product)\Naphazoline (substance)\...

\Naphazoline-containing product in ocular dose form\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

\Product containing naphazoline and pheniramine (medicinal product)\Product containing naphazoline and pheniramine in ocular dose form (medicinal product form)\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution
\Product containing naphazoline and pheniramine (medicinal product)\Naphazoline and pheniramine only product\Naphazoline and pheniramine only product in ocular dose form\Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3762870015 Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3762871016 Product containing precisely naphazoline hydrochloride 250 microgram/1 milliliter and pheniramine maleate 3 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2466365014 Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2466365014 Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2472561019 Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2472561019 Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3762870015 Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3762871016 Product containing precisely naphazoline hydrochloride 250 microgram/1 milliliter and pheniramine maleate 3 milligram/1 milliliter conventional release eye solution (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Is a	Naphazoline hydrochloride+pheniramine	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Pheniramine maleate	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Naphazoline hydrochloride (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Pheniramine (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Is a	Product containing naphazoline in ophthalmic dosage form	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has manufactured dose form	Eye solution	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Is a	Product containing naphazoline and pheniramine (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Naphazoline (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength denominator unit (attribute)	Milliliter (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength denominator unit (attribute)	Milliliter (qualifier value)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength denominator value	un	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Count of base of active ingredient	deux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Is a	Naphazoline and pheniramine only product in ocular dose form	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has basis of strength substance (attribute)	Naphazoline hydrochloride (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has precise active ingredient	Naphazoline hydrochloride (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength numerator unit	mcg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength numerator value	trois	false	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has basis of strength substance (attribute)	Pheniramine maleate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength numerator value	250	false	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has concentration strength numerator unit	mg	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	Has precise active ingredient	Pheniramine maleate	true	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3762870015	Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3762871016	Product containing precisely naphazoline hydrochloride 250 microgram/1 milliliter and pheniramine maleate 3 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2466365014	Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution (product)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2466365014	Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution (product)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2472561019	Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2472561019	Naphazoline hydrochloride 0.025%/pheniramine maleate 0.3% ophthalmic solution	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3762870015	Naphazoline hydrochloride 250 microgram/mL and pheniramine maleate 3 mg/mL eye solution	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3762871016	Product containing precisely naphazoline hydrochloride 250 microgram/1 milliliter and pheniramine maleate 3 milligram/1 milliliter conventional release eye solution (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core